自1995年2月到1996年7月，我院使用美施康定──硫酸吗啡控释片治疗中重度癌性疼痛103例，结果CR36例。占34.9％，PR59冽、占57．28％，NC8例、占7．77％，总有效率（CR＋PR）为92.24％，大部分病人剂量用30mg，q12h，能有效控制疼痛，副作用大部分病人均可耐受，未见呼吸抑制、血压下降和药物依赖性出现。本研究结果表明：美施康定作为控制中重度癌痛的药物，镇痛效果满意，副作用较轻，服用方厘、安全，值得临床推广应用。 From February 1995 to July 1996, our hospital used Meishi Kangding ─ ─ morphine sulfate controlled release tablets in the treatment of 103 cases of moderate to severe cancer pain, the results of CR36 cases. Accounting for 34.9%, PR59%, accounting for 57.28%, NC8 cases, accounting for 7.77%, the total effective rate (CR + PR) was 92.24%, most patients dose 30mg, q12h, can effectively control the pain, side effects most patients Can be tolerated, no respiratory depression, blood pressure and drug dependence appear. The results of this study show that: As a medicament for controlling moderate-to-severe cancer pain, Meishi Kangding has satisfactory analgesic effect, less side effects, and is safe and worthy of clinical application.